In detail, the authors reported that the cotreatment of HT-29 colon cancer cells with RA reduced TPA-induced COX-2 promoter activity and protein levels; furthermore, RA antagonized the AP-1-dependent activation of COX-2 transcription [80]. This evidence concerns the gene PTGS2 and colonic neoplasm.